Cover Image

Comparison of Different Methods for Assaying the In Vitro Activity of Cefiderocol against Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Strains: Influence of Bacterial Inoculum

Carbapenem-resistant <i>Pseudomonas aeruginosa</i> infections represent a critical public health concern, highlighting the need for the development of effective antibiotics. Cefiderocol demonstrated potent in vitro activity against <i>Pseudomonas aeruginosa</i>, particularly...

Full description

Saved in:

Bibliographic Details
Main Authors:	Celia García-Rivera (Author), Antonia Sánchez-Bautista (Author), Mónica Parra-Grande (Author), Andrea Ricart-Silvestre (Author), María Paz Ventero (Author), Iryna Tyshkovska (Author), Esperanza Merino (Author), Juan Carlos Rodríguez Díaz (Author)
Format:	Book
Published:	MDPI AG, 2024-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Role of Relebactam in the Antibiotic Resistance Acquisition in <i>Pseudomonas aeruginosa</i>: In Vitro Study
by: Maria Paz Ventero, et al.
Published: (2023)

Clinical Significance of Carbapenem-Tolerant <i>Pseudomonas aeruginosa</i> Isolated in the Respiratory Tract
by: Momoyo Azuma, et al.
Published: (2020)

Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Arta Karruli, et al.
Published: (2023)

Correlation between Carbapenem Consumption and Carbapenems Susceptibility Profiles of <i>Acinetobacter baumannii</i> and <i>Pseudomonas aeruginosa</i> in an Academic Medical Center in Thailand
by: Taniya Paiboonvong, et al.
Published: (2022)

The Efficacy of Topical Cefiderocol Treatment of Experimental Extensively Drug-Resistant <i>Pseudomonas aeruginosa</i> Keratitis Is Dependent upon the State of the Corneal Epithelium
by: Eric G. Romanowski, et al.
Published: (2024)

Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Strains-Distribution of the Essential Enzymatic Virulence Factors Genes
by: Tomasz Bogiel, et al.
Published: (2020)

Challenges Facing Two Outbreaks of Carbapenem-Resistant <i>Acinetobacter baumannii</i>: From Cefiderocol Susceptibility Testing to the Emergence of Cefiderocol-Resistant Mutants
by: Montserrat Rodríguez-Aguirregabiria, et al.
Published: (2024)

Optimizing Doses of Ceftolozane/Tazobactam as Monotherapy or in Combination with Amikacin to Treat Carbapenem-Resistant <i>Pseudomonas aeruginosa</i>
by: Worapong Nasomsong, et al.
Published: (2022)

Carbapenem Combinations for Infections Caused by Carbapenemase-Producing <i>Pseudomonas aeruginosa</i>: Experimental In Vitro and In Vivo Analysis
by: Soraya Herrera-Espejo, et al.
Published: (2022)

Carbapenem-Resistant but Cephalosporin-Susceptible <i>Pseudomonas aeruginosa</i> in Urinary Tract Infections: Opportunity for Colistin Sparing
by: Márió Gajdács
Published: (2020)

Molecular Analysis of Carbapenem and Aminoglycoside Resistance Genes in Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Clinical Strains: A Challenge for Tertiary Care Hospitals
by: Aamir Jamal Gondal, et al.
Published: (2024)

<i>Pseudomonas aeruginosa</i> Biofilm Formation, Infections and Treatments
Published: (2021)

In Vitro Activities and Inoculum Effects of Ceftazidime-Avibactam and Aztreonam-Avibactam against Carbapenem-Resistant <i>Enterobacterales</i> Isolates from South Korea
by: Taeeun Kim, et al.
Published: (2020)

Bloodstream Infections Due to Wild-Type <i>Pseudomonas aeruginosa</i>: Carbapenems and Ceftazidime/Avibactam Prescription Rate and Impact on Outcomes
by: Carlo Pallotto, et al.
Published: (2024)

In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates
by: Harald Seifert, et al.
Published: (2023)

Cefiderocol for Severe Carbapenem-Resistant <i>A. baumannii</i> Pneumonia: Towards the Comprehension of Its Place in Therapy
by: Emanuele Rando, et al.
Published: (2021)

Transmission cluster of cefiderocol-non-susceptible carbapenem-resistant Acinetobacter baumannii in cefiderocol-naïve individuals
by: Claudia Alteri, et al.
Published: (2024)

Treatment Heterogeneity in <i>Pseudomonas aeruginosa</i> Pneumonia
by: Aisling R. Caffrey, et al.
Published: (2022)

Clinical Outcome of Cefiderocol for Infections with Carbapenem-Resistant Organisms
by: Monirul I. Sajib, et al.
Published: (2023)

Carbapenem-Only Combination Therapy against Multi-Drug Resistant <i>Pseudomonas aeruginosa</i>: Assessment of In Vitro and In Vivo Efficacy and Mode of Action
by: Brendan Mackay, et al.
Published: (2022)

Insights into the Rising Threat of Carbapenem-Resistant Enterobacterales and <i>Pseudomonas aeruginosa</i> Epidemic Infections in Eastern Europe: A Systematic Literature Review
by: Michal Piotrowski, et al.
Published: (2024)

Comparison between Colistin and Polymyxin B in the Treatment of Bloodstream Infections Caused by Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii-calcoaceticus Complex</i>
by: Rebeca Carvalho Lacerda Garcia, et al.
Published: (2023)

Antimicrobial Treatment of <i>Pseudomonas aeruginosa</i> Severe Sepsis
by: Johnny Zakhour, et al.
Published: (2022)

The Basis for Natural Multiresistance to Phage in <i>Pseudomonas aeruginosa</i>
by: Christine Pourcel, et al.
Published: (2020)

Survey of VA Laboratory Practices for Carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa
by: Aubrey Sawyer, et al.
Published: (2024)

Comparative In Vitro Activity of Ceftazidime-Avibactam, Imipenem-Relebactam, and Meropenem-Vaborbactam against Carbapenem-Resistant Clinical Isolates of <i>Klebsiella pneumoniae</i> and <i>Pseudomonas aeruginosa</i>
by: Anthony Sophonsri, et al.
Published: (2024)

Clinical and Economic Burden of Carbapenem-Resistant Infection or Colonization Caused by <i>Klebsiella pneumoniae</i>, <i>Pseudomonas aeruginosa</i>, <i>Acinetobacter baumannii</i>: A Multicenter Study in China
by: Xuemei Zhen, et al.
Published: (2020)

Spiramycin Disarms <i>Pseudomonas aeruginosa</i> without Inhibiting Growth
by: Matteo Calcagnile, et al.
Published: (2023)

Bacteriophage-Antibiotic Combination Therapy against <i>Pseudomonas aeruginosa</i>
by: Guillermo Santamaría-Corral, et al.
Published: (2023)

Sub-Inhibitory Antibiotic Exposure and Virulence in <i>Pseudomonas aeruginosa</i>
by: Charlotte Nolan, et al.
Published: (2021)

Detection of extended-spectrum β-lactamase in <i>Pseudomonas aeruginosa</i>
by: Aggarwal Ritu, et al.
Published: (2008)

Carbapenem Resistance Related with Biofilm Formation and Pilin Genes in Clinical Pseudomonas aeruginosa Isolates
by: Huda M. Mahmood, et al.
Published: (2024)

Trends in <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) Bacteremia during the COVID-19 Pandemic: A Systematic Review
by: Qin Xiang Ng, et al.
Published: (2023)

Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant <i>Pseudomonas aeruginosa</i>
by: Addisu D. Teklemariam, et al.
Published: (2023)

Antimicrobial susceptibility of <i>Pseudomonas aeruginosa</i> isolated from wound infections
by: Anupurba Shampa, et al.
Published: (2006)

Exposure of <i>Pseudomonas aeruginosa</i> to Cinnamaldehyde Selects Multidrug Resistant Mutants
by: Alexandre Tetard, et al.
Published: (2022)

Intravenous Fosfomycin for Systemic Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Infections
by: Giuseppe Pipitone, et al.
Published: (2023)

Characteristics of Antibiotic Resistance and Tolerance of Environmentally Endemic <i>Pseudomonas aeruginosa</i>
by: Seryoung Kim, et al.
Published: (2022)

Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by <i>Pseudomonas aeruginosa</i>
by: George L. Daikos, et al.
Published: (2021)

Thermal Shock and Ciprofloxacin Act Orthogonally on <i>Pseudomonas aeruginosa</i> Biofilms
by: Haydar Aljaafari, et al.
Published: (2021)